A PE-backed medical technology company in Oxford specialising in organ preservation has completed a $142m primary and secondary equity financing.

OrganOx, a British developer of technologies to maintain organs for transplant, raised $142m in primary and secondary funding ...

OrganOx 's metra normothermic machine perfusion platform gained approval in Australia, Europe, Canada, and the US.

OrganOx announced today that it completed a $142 million primary and secondary equity financing to accelerate growth opportunities.

Financing strengthens OrganOx to expand its leadership position in organ technologyOXFORD, United Kingdom and MADISON, N.J., Feb. 24, 2025., a leading organ medical technology company, successfully co ...

OrganOx, with its system for actively preserving viable donor tissue ahead of a transplant procedure, has raised $142 million ...